Articles tagged "Liver transplantation"

2022 American Transplant Congress
Meld/Peld Exception Policy and Outcomes in Children with Hepatopulmonary Syndrome Requiring Liver Transplantation in the United States
M. H. Raza¹, P. Kobierski¹, A. Misra², A. Lim³, C. Goldbeck², K. Etesami², R. Kohli⁴, J. Emamaullee²
¹Keck School of Medicine of USC, Los Angeles, CA, ²Surgery, University of Southern California, Los Angeles, CA, ³University of Southern California, Los Angeles, CA, ⁴Liver Transplant Program, Children's Hospital-Los Angeles, Los Angeles, CA
*Purpose: Hepatopulmonary syndrome (HPS) is associated with increased waitlist mortality in liver transplant (LT) candidates. Children with HPS are currently granted MELD/PELD exception for LT…
2022 American Transplant Congress
Cytomegalovirus Prophylaxis in Pediatric Liver Transplantation: A Comparison of Strategies Across the SPLIT Consortium
E. D. Knackstedt¹, S. G. Anderson², R. Anand², J. Mitchell², J. Bucuvalas³, L. Danziger-Isakov⁴
¹Univ of Utah/Primary Children's Hosp, SLC, UT, ²Emmes, Rockville, MD, ³Icahn School of Med at Mount Sinai, New York City, NY, ⁴Cincinnati Children's Hosp Med Ctr, Cincinnati, OH
*Purpose: To compare the effectiveness of short (180d) cytomegalovirus (CMV) prophylaxis in pediatric liver transplantation (pLTX).*Methods: A prospective cohort study of primary pLTX (≤18 yrs…
2022 American Transplant Congress
Portal Vein Challenges in Pediatric Liver Transplantation: The Utility of Interposition Grafts as an Acceptable Management Strategy
K. Etesami¹, R. Hogen², J. Cervantes³, Y. Kwon⁴, S. Zielsdorf³, J. Emamaullee³, Y. Genyk³
¹Surgery, Children's Hospital Los Angeles, Los Angeles, CA, ²University of Southern California, West Hollywood, CA, ³University of Southern California, Los Angeles, CA, ⁴Hepatobiliary and Abdominal Transplant Surgery, University of Southern California, Los Angeles, CA
*Purpose: Portal vein (PV) anomalies and portal vein thrombosis (PVT) can present as challenging cases in the pediatric cohort, necessitating analysis and an algorithmic approach.*Methods:…
2022 American Transplant Congress
Pre-Transplant Evaluation of Patients Undergoing Combined Heart-Liver Transplantation and Correlation with Explant Pathology
A. Shingina¹, J. N. Menachem¹, S. Brown¹, I. A. Ziogas², W. K. Wu³, M. J. Izzy⁴, J. Liang¹, K. Washington¹, S. Alexopoulos⁵
¹Vanderbilt University Medical Center, Nashville, TN, ²Division of Hepatobiliary Surgery and Liver Transplantation, Vanderbilt University Medical Center, Nashville, TN, ³Thoracic Surgery; Hepatobiliary Surgery and Liver Transplantation, Vanderbilt University Medical Center, Nashville, TN, ⁴GI and Hepatology, Vanderbilt University Medical Center, Nashville, TN, ⁵Vanderbilt Medical Center, Nashville, TN
*Purpose: Fontan-associated liver disease (FALD) is a well-described complication of Fontan physiology. More patients with failing Fontan are being evaluated for heart transplant and evidence-based…
2022 American Transplant Congress
Safety and Efficacy at 4 Years in Post-Liver Transplant Patients with Chronic Kidney Disease Receiving Tenofovir Alafenamide (TAF) for HBV Prophylaxis
E. Gane¹, B. George¹, D. Ray-Chaudhuri¹, T. Mules¹, C. D. Holt², H. Wang², V. Suri², A. Gaggar², A. Osinusi², J. Flaherty²
¹Auckland City Hospital and University of Auckland, Auckland, New Zealand, ²Gilead Sciences, Inc., Foster City, CA
*Purpose: Recommended antiviral prophylaxis to prevent recurrent HBV infection after liver transplantation includes tenofovir disoproxil fumarate (TDF). However, given risks of bone/renal toxicity associated with…
2022 American Transplant Congress
Liver Transplant Recipient History of Criminality: Impact on Clinical Outcomes
M. M. French¹, R. Mangus¹, R. Holmes¹, A. Krause¹, J. Sumner¹, C. Kubal¹, B. Ekser², P. Mihaylov³, A. Lutz⁴, J. Fridell⁵
¹Department of Surgery, Indiana University, Indianapolis, IN, ²Surgery, Indiana University - Transplant Surgery, Indianapolis, IN, ³Department of Surgery, Indiana Univ School of Medicine, Indianapolis, IN, ⁴Department of Surgery, Indiana University, Fishers, IN, ⁵Department of Surgery, Indiana University School of Medicine, Indianapolis, IN
*Purpose: Health disparities are present in transplantation, just as in other areas of medicine. This is a retrospective review of liver transplant (LT) recipients to…
2022 American Transplant Congress
Predictive Value of Abnormal Hemodynamic Response to Dobutamine Stress Echocardiography in Liver Transplant Recipients
M. Groose, A. Peotter, L. Hammel
University of Wisconsin Hospitals and Clinics, Madison, WI
*Purpose: Dobutamine stress echocardiography (DSE) is an effective tool for perioperative cardiac risk stratification in patients without end-stage liver disease (ESLD). However, DSE is frequently…
2022 American Transplant Congress
An In Depth Assessment of Unsuccessful DCD Donor Procurement Attempts: Areas for Improvement
M. Rosenzweig, M. Finotti, E. Martinez, S. Lee, A. Gupta, A. Wall, J. Bayer, H. Fernandez, N. Onaca, R. Ruiz, G. J. McKenna
Baylor Simmons Transplant Institute, Baylor University Medical Center, Dallas, TX
*Purpose: DCD donors are a key way to expand allograft supply but an aggressive strategy of pursuing DCD liver allografts is associated with significant number…
2022 American Transplant Congress
Pulmonary Function Tests and Liver Transplantation
D. Reino¹, P. Martinez², K. Robichaux³, M. Gosselin⁴, S. Mohammed³, J. Buggs¹, A. Kumar⁵
¹Transplant Surgery, Tampa General Hospital, Tampa, FL, ²University of Miami, Miami, FL, ³University of South Florida, Tampa, FL, ⁴University of Tampa, Tampa, FL, ⁵Morsani College of Medicine, University of South Florida, Tampa, FL
*Purpose: Liver transplant recipients have a high risk of developing postoperative pulmonary complications. Pulmonary function tests (PFTs) are expensive and often incapable of predicting patients…
2022 American Transplant Congress
Role of Circulating Tumour Cells in the Management of the Liver Transplant Patient with Hepatocellular Carcinoma
F. Villalba¹, F. Alconchel², L. Sáenz³, M. Sánchez-Lorencio¹, D. Ferreras², P. Cascales², F. Sánchez-Bueno², R. Robles², P. Ramírez²
¹IMIB-Virgen de la Arrixaca, Murcia, Spain, ²Surgery and Organ Transplantation, Virgen de la Arrixaca University Hospital (IMIB-Virgen de la Arrixaca), Murcia, Spain, ³Rafael Méndez Hospital, Lorca, Spain
*Purpose: For hepatocellular carcinoma (HCC), liver transplantation (LT) is considered a curative treatment, however, more than 10% of transplant recipients have recurrences within the first…

1
2
3
…
180
Next Page »